139 related articles for article (PubMed ID: 27158783)
1. A Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis.
Scholz E; Mestre-Ferrer A; Daura X; García-Medel N; Carrascal M; James EA; Kwok WW; Canals F; Álvarez I
Arthritis Rheumatol; 2016 Oct; 68(10):2412-21. PubMed ID: 27158783
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
3. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
4. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
[TBL] [Abstract][Full Text] [Related]
5. The rheumatoid arthritis-associated allele HLA-DR10 (DRB1*1001) shares part of its repertoire with HLA-DR1 (DRB1*0101) and HLA-DR4 (DRB*0401).
Alvarez I; Collado J; Daura X; Colomé N; Rodríguez-García M; Gallart T; Canals F; Jaraquemada D
Arthritis Rheum; 2008 Jun; 58(6):1630-9. PubMed ID: 18512783
[TBL] [Abstract][Full Text] [Related]
6. The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.
Ting YT; Petersen J; Ramarathinam SH; Scally SW; Loh KL; Thomas R; Suri A; Baker DG; Purcell AW; Reid HH; Rossjohn J
J Biol Chem; 2018 Mar; 293(9):3236-3251. PubMed ID: 29317506
[TBL] [Abstract][Full Text] [Related]
7. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins.
Auger I; Escola JM; Gorvel JP; Roudier J
Nat Med; 1996 Mar; 2(3):306-10. PubMed ID: 8612229
[TBL] [Abstract][Full Text] [Related]
9. Association of rheumatoid arthritis with HLA-DR1 and HLA-DR4 in Hungary.
Kapitány A; Zilahi E; Szántó S; Szücs G; Szabó Z; Végvári A; Rass P; Sipka S; Szegedi G; Szekanecz Z
Ann N Y Acad Sci; 2005 Jun; 1051():263-70. PubMed ID: 16126967
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses.
Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL
Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734
[TBL] [Abstract][Full Text] [Related]
11. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
12. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
Phelps RG; Jones V; Turner AN; Rees AJ
Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1 gene sequences in HLA-DR4 positive and negative patients with rheumatoid arthritis.
Becking A; Pluschke G; Krawinkel U; Melchers I; Peter HH; Lang B
Eur J Immunogenet; 1993 Apr; 20(2):83-9. PubMed ID: 8494871
[TBL] [Abstract][Full Text] [Related]
14. A distinctive peptide binding motif for HLA-DRB1*0407, an HLA-DR4 subtype not associated with rheumatoid arthritis.
Davenport MP; Godkin A; Friede T; Stevanović S; Willis AC; Hill AV; Rammensee HG
Immunogenetics; 1997; 45(3):229-32. PubMed ID: 8995193
[No Abstract] [Full Text] [Related]
15. HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype.
de Vries N; Rønningen KS; Tilanus MG; Bouwens-Rombouts A; Segal R; Egeland T; Thorsby E; van de Putte LB; Brautbar C
Tissue Antigens; 1993 Jan; 41(1):26-30. PubMed ID: 8456440
[TBL] [Abstract][Full Text] [Related]
16. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association.
Hammer J; Gallazzi F; Bono E; Karr RW; Guenot J; Valsasnini P; Nagy ZA; Sinigaglia F
J Exp Med; 1995 May; 181(5):1847-55. PubMed ID: 7722459
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
[TBL] [Abstract][Full Text] [Related]
18. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
[TBL] [Abstract][Full Text] [Related]
19. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
Rosloniec EF; Ivey RA; Whittington KB; Kang AH; Park HW
J Immunol; 2006 Sep; 177(6):3884-92. PubMed ID: 16951351
[TBL] [Abstract][Full Text] [Related]
20. The N-terminal six residues of peptide core sequences suffice for binding to HLA-DR4 (DRB1*0405) and DR9 (DRB1*0901) molecules.
Matsushita S; Fujisao S; Nishimura Y
Immunol Lett; 1997 Jul; 58(2):89-93. PubMed ID: 9271318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
